Syndecan-1 (CD138) expression in acute myeloblastic leukemia cells - An immuno electron microscopic study

被引:5
|
作者
Seftalioglu, A
Karakus, S
Dundar, S
Can, B
Erdemli, E
Irmak, MK
Oztas, E
Korkmaz, C
Yazar, F
Cavusoglu, I
机构
[1] Hacettepe Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Hematol, TR-06100 Ankara, Turkey
[3] Ankara Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey
[4] Gulhane Mil Med Acad, Dept Histol & Embryol, Ankara, Turkey
[5] Gulhane Mil Med Acad, Dept Anat, Ankara, Turkey
[6] Uludag Univ, Fac Med, Dept Histol & Embryol, Bursa, Turkey
关键词
D O I
10.1080/0891060310002267
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Syndecan-1 (CD138), an important transmembrane heparan sulfate proteoglycan is expressed in distinct stages of cell differentiation. Although its expression in acute lymphoblastic leukemia (ALL) cells is well known; its function or presence in acute myeloblastic leukemia (AML) cells is still largely unknown. The expression of syndecan-1 was studied in bone marrow biopsies of three patients with AML using electron microscopic immunocytochemistry. Positive expression of syndecan-1 was found in AML cells. These results suggest that syndecan-1 expression is not only a characteristic phenotypic marker for ALL, but is also expressed in AML cells.
引用
收藏
页码:71 / 74
页数:4
相关论文
共 50 条
  • [1] Syndecan-1/CD138 expression in normal myeloid, acute lymphoblastic and myeloblastic leukemia cells
    Seftalioglu, A
    Karakus, S
    ACTA HISTOCHEMICA, 2003, 105 (03) : 213 - 221
  • [2] Syndecan-1 (CD138) expression in adenocarcinomas of the endometrium
    Willis, C
    Olson, S
    Washington, K
    Shappell, H
    MODERN PATHOLOGY, 2003, 16 (01) : 214A - 214A
  • [3] Syndecan-1 (CD138) expression in adenocarcinomas of the endometrium
    Willis, C
    Olson, S
    Washington, K
    Shappell, H
    LABORATORY INVESTIGATION, 2003, 83 (01) : 214A - 214A
  • [4] CD138 (syndecan-1) expression in health and disease
    Palaiologou, Marina
    Delladetsima, Ioanna
    Tiniakos, Dina
    HISTOLOGY AND HISTOPATHOLOGY, 2014, 29 (02) : 177 - 189
  • [5] Syndecan-1 (CD138), Carcinomas and EMT
    Couchman, John R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [6] Prognostic Significance of CD138 (Syndecan-1) Expression in Autoimmune Hepatitis
    Romano, Adriana F.
    Sauma-Rodriguez, Johanna
    Ramos-Martinez, Paris
    Torre, Aldo
    GASTROENTEROLOGY, 2014, 146 (05) : S1008 - S1008
  • [7] CD138 (Syndecan-1) Expression in Bone-Forming Tumors
    Nunez, Amberly L.
    Siegal, Gene P.
    Reddy, Vishnu V. B.
    Wei, Shi
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (03) : 423 - 428
  • [8] Down expression of syndecan-1 (CD138) in nasopharyngeal carcinoma (NPC)
    Chen, CL
    MODERN PATHOLOGY, 2005, 18 : 211A - 212A
  • [9] Differential expression of syndecan-1 (CD138) in myxoid soft TissueTumors
    Liu, J.
    Haupt, H. M.
    Brooks, J. J.
    MODERN PATHOLOGY, 2007, 20 : 18A - 18A
  • [10] Down expression of syndecan-1 (CD138) in nasopharyngeal carcinoma (NPC)
    Chen, CL
    LABORATORY INVESTIGATION, 2005, 85 : 211A - 212A